{"2021-11-30": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Asian FX, stocks pare gains on Moderna CEO's Omicron warning - Reuters", "description": "Emerging Asian equities and currencies trimmed gains on Tuesday on concerns that the Omicron coronavirus variant could prove more resistant to existing vaccines, while South Korean shares dropped over 2% on weak domestic data.", "url": "https://www.reuters.com/markets/stocks/asian-fx-stocks-pare-gains-moderna-ceos-omicron-warning-2021-11-30/", "urlToImage": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.png?d=60", "publishedAt": "2021-11-30T08:02:00Z", "content": "Nov 30(Reuters) - Emerging Asian equities and currencies trimmed gains on Tuesday on concerns that the Omicron coronavirus variant could prove more resistant to existing vaccines, while South Korean \u2026 [+2829 chars]"}], "2021-12-10": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Tesla, Southwest Airlines, Snap Inc, Moderna, SM Energy - Reuters", "description": "U.S. stock indexes rose on Friday after data showed consumer prices rose largely in line with estimates last month, taking some pressure off investors concerned about the Federal Reserve's aggressive tightening of its monetary policy.", "url": "https://www.reuters.com/markets/asia/tesla-southwest-airlines-snap-inc-moderna-sm-energy-2021-12-10/", "urlToImage": "https://www.reuters.com/pf/resources/images/reuters/reuters-default.png?d=63", "publishedAt": "2021-12-10T15:55:00Z", "content": "U.S. stock indexes rose on Friday after data showed consumer prices rose largely in line with estimates last month, taking some pressure off investors concerned about the Federal Reserve's aggressive\u2026 [+2796 chars]"}], "2021-12-02": [{"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "Moderna may have Omicron booster by March | Reuters Video - Reuters.com", "description": "Moderna could have a COVID-19 booster shot targeting the Omicron variant tested and ready to file for U.S. authorization as soon as March, the company's president said on Wednesday. Fred Katayama reports.", "url": "https://www.reuters.com/video/watch/idOVF6COH3F", "urlToImage": "https://static.reuters.com/resources/r/?d=20211202&i=OVF6COH3F&r=OVF6COH3F&t=2", "publishedAt": "2021-12-02T16:54:12Z", "content": "Posted \r\nModerna could have a COVID-19 booster shot targeting the Omicron variant tested and ready to file for U.S. authorization as soon as March, the company's president said on Wednesday. Fred Kat\u2026 [+13 chars]"}], "2021-12-17": [{"source": {"id": "reuters", "name": "Reuters"}, "author": "Reuters Editorial", "title": "CDC panel recommends Pfizer, Moderna over J&J shot - Reuters", "description": "A panel of outside advisers to the U.S. Centers for Disease Control and Prevention on Thursday voted to recommend Americans choose to receive one of the other two authorized COVID-19 vaccines over Johnson & Johnson's shot, due to rare but sometimes fatal case\u2026", "url": "https://www.reuters.com/video/watch/idPBOo?now=true", "urlToImage": "https://ajo.prod.reuters.tv/api/v2/img/61bbd0a4e4b09631b0e445ba-1639698596092?location=LANDSCAPE", "publishedAt": "2021-12-17T00:11:20Z", "content": "Posted \r\nA panel of outside advisers to the U.S. Centers for Disease Control and Prevention on Thursday voted to recommend Americans choose to receive one of the other two authorized COVID-19 vaccine\u2026 [+92 chars]"}], "2021-12-20": [{"source": {"id": null, "name": "NPR"}, "author": "Jaclyn Diaz", "title": "Moderna says its COVID booster increases protection against omicron", "description": "Moderna said its current FDA-approved 50-microgram booster shot increased antibody levels against omicron 37-fold compared to pre-booster levels.", "url": "https://www.npr.org/2021/12/20/1065734884/moderna-says-its-covid-booster-increases-protection-against-omicron", "urlToImage": "https://media.npr.org/assets/img/2021/12/20/ap21350469730902_wide-0d598730107da05c19468e3d800be749c0460327.jpg?s=1400", "publishedAt": "2021-12-20T11:11:33Z", "content": "Moderna said Monday preliminary data showed its COVID-19 booster shot is effective against the omicron variant of the coronavirus currently surging in the U.S. and around the world.\r\nThe pharmaceutic\u2026 [+904 chars]"}], "2021-12-23": [{"source": {"id": null, "name": "Zacks.com"}, "author": "Zacks Equity Research", "title": "Moderna (MRNA) Down as Pfizer Paxlovid EUA May Fuel Competition", "description": "Moderna's (MRNA) COVID-19 vaccine may face stiffer competition following the FDA's emergency approval of an oral COVID-19 pill, Pfizer's Paxlovid, which may result in lower sales.", "url": "http://www.zacks.com/stock/news/1842878/moderna-mrna-down-as-pfizer-paxlovid-eua-may-fuel-competition?cid=CS-ENTREPRENEUR-FT-analyst_blog|company_news_-_medical_sector-1842878", "urlToImage": "https://assets.entrepreneur.com/providers/zacks/hero-image-zacks-404475.jpeg", "publishedAt": "2021-12-23T15:39:00Z", "content": "Shares of popular COVID-19 vaccine-maker, ModernaMRNA were down 6.3% on Wednesday, following the news of emergency use authorization (EUA) for Pfizers PFE promising oral COVID-19 pill, Paxlovid, in t\u2026 [+7367 chars]"}], "2021-12-22": [{"source": {"id": null, "name": "Tbnewswatch.com"}, "author": "Leith Dunick", "title": "Health unit switching to mainly Moderna vaccines - Tbnewswatch.com", "description": "Health unit switching to mainly Moderna vaccines\u00a0\u00a0Tbnewswatch.comView Full coverage on Google News", "url": "https://www.tbnewswatch.com/coronavirus-covid-19-local-news/health-unit-switching-to-mainly-moderna-vaccines-4893157", "urlToImage": "https://www.vmcdn.ca/f/files/townandcountrytoday/images/moderna-vaccine.jpg;w=1200;h=800;mode=crop", "publishedAt": "2021-12-22T23:30:00Z", "content": "THUNDER BAY -- The Thunder Bay District Health Unit is switching to Moderna'sSpikeVax as its primary vaccine moving forward.\r\nThe health unit on Wdnesday said the move will be made mainly due to supp\u2026 [+1390 chars]"}], "2021-12-06": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response -UK study - Reuters", "description": "A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/mixing-pfizer-astraz-covid-19-shots-with-moderna-gives-better-immune-response-uk-2021-12-06/", "urlToImage": "https://www.reuters.com/resizer/2hWWuQQtDAfsE2_em2jdEEeltMw=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/P3XCTOZZEJKGRERRQ6XNXOCXUU.jpg", "publishedAt": "2021-12-06T23:40:00Z", "content": "Dec 6 (Reuters) - A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots follow\u2026 [+3422 chars]"}], "2021-12-01": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Moderna exec says company could have Omicron booster ready in March - Reuters", "description": "Moderna Inc <a href=\"https://www.reuters.com/companies/MRNA.O\" target=\"_blank\">(MRNA.O)</a> could have a COVID-19 booster shot targeting the Omicron variant tested and ready to file for U.S. authorization as soon as March, the company's president said on Wedn\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-exec-says-company-could-have-omicron-booster-ready-march-2021-12-01/", "urlToImage": "https://www.reuters.com/resizer/V-emukdLzpodyAgK9a6EjkNy6bU=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZIV5R25AABINFPNCMEOPSZQP7U.jpg", "publishedAt": "2021-12-01T19:56:00Z", "content": "NEW YORK, Dec 1 (Reuters) - Moderna Inc (MRNA.O) could have a COVID-19 booster shot targeting the Omicron variant tested and ready to file for U.S. authorization as soon as March, the company's presi\u2026 [+3401 chars]"}], "2021-12-16": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Japan adds Moderna shot to COVID vaccine booster arsenal, joining Pfizer - Reuters", "description": "Japan on Thursday officially approved Moderna Inc's <a href=\"https://www.reuters.com/companies/MRNA.O\" target=\"_blank\">(MRNA.O)</a> COVID-19 vaccine for its booster shot programme that began this month.", "url": "https://www.reuters.com/world/asia-pacific/japan-adds-moderna-shot-covid-vaccine-booster-arsenal-joining-pfizer-2021-12-16/", "urlToImage": "https://www.reuters.com/resizer/DNWCKjP-UTc21x4Fij5lqVdfy-U=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/LXZ7Q7HUERO4LJ6MQSEN5X7GLE.jpg", "publishedAt": "2021-12-16T03:19:00Z", "content": "TOKYO, Dec 16 (Reuters) - Japan on Thursday officially approved Moderna Inc's (MRNA.O) COVID-19 vaccine for its booster shot programme that began this month.\r\nThe move followed a recommendation from \u2026 [+1316 chars]"}], "2021-12-21": [{"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Moderna could be ready to develop Omicron booster in weeks - CEO - Reuters", "description": "COVID-19 vaccine maker Moderna <a href=\"https://www.reuters.com/companies/MRNA.O\" target=\"_blank\">(MRNA.O)</a> does not expect any problems in developing a booster shot to protect against the Omicron variant of the coronavirus and could begin work in a few we\u2026", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-could-be-ready-develop-omicron-booster-weeks-ceo-2021-12-21/", "urlToImage": "https://www.reuters.com/resizer/vFCsqhKPg-HAAWgX-qlg38-H9mk=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/L7LSITQGFBJWLHA756XMPIQYCU.jpg", "publishedAt": "2021-12-21T07:42:00Z", "content": "ZURICH, Dec 21 (Reuters) - COVID-19 vaccine maker Moderna (MRNA.O) does not expect any problems in developing a booster shot to protect against the Omicron variant of the coronavirus and could begin \u2026 [+2619 chars]"}]}